Mediation of in vivo analyte signal degradation
US12419551B2 · kind B2 · utility
0Cited by
11References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 2020 |
| Grant date | Sep 23, 2025 |
| Priority date | — |
| Expiry date | Mar 24, 2044 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B2562/18
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A sensor (e.g., an optical sensor) that may be implanted within a living animal (e.g., a human) and may be used to measure an analyte (e.g., glucose or oxygen) in a medium (e.g., interstitial fluid, blood, or intraperitoneal fluid) within the animal. The sensor may include a sensor housing, an analyte indicator covering at least a portion of the sensor housing, and one or more compounds having dithio-, thio- or mercapto-containing moieties that reduce degradation of the analyte indicator.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.